Regeneron Pharmaceuticals, Inc. has announced five-year follow-up results from its Phase 3 EMPOWER...
Author - Farrukh Hassan
Glycomine Begins Global Phase 2b Clinical Trial of GLM101 for...
Glycomine, Inc., a clinical-stage biotechnology company, has announced the initiation of dosing in...
Case Study: PostNord TPL ensures GDP compliance with Vaisala’s...
PostNord TPL, part of the PostNord Group, operates one of the largest third-party logistics...
SeqOne to Acquire Congenica to Establish Global Leader in AI...
SeqOne has entered into a definitive agreement to acquire Congenica, the UK genomics company spun...
AbbVie shares Phase 2 EPCORE® NHL-6 data: outpatient first-full...
AbbVie has reported updated results from the Phase 2 EPCORE® NHL-6 study (NCT05451810) assessing...
Roche Receives CE Mark for Contivue Port Delivery Platform in...
Roche has announced that the European Union has granted CE Mark approval for Contivue®, its Port...
NoPalm Ingredients and NIZO Launch First Yeast Oil Demonstration...
NoPalm Ingredients has partnered with NIZO to establish the first yeast oil demonstration factory...